FIELD: medicine. SUBSTANCE: this preparation includes 11.0 to 15.7 percent by mass cytochrome C, 0.5 to 0.6 percent by mass nicotinamideadenine dinucleotide and 82.8 to 88.6 percent by mass inosine which should be administered intravenously at daily dosage of 10.0, 0.5 and 80.0 mg/kg. EFFECT: disclosed combination remedy is capable of harmonically normalizing functionability of various links within energetic system of cardiomyocyte, normalizing intensity of glycolytic oxide reduction, oxidizing phosphorylation in mytochondria, and synthesis of adenine and guanine nucleotides.
| Title | Year | Author | Number |
|---|---|---|---|
| CARDIOTROPIC PREPARATION | 1991 |
|
RU2035908C1 |
| ANTIHYPOXIC AGENT | 1994 |
|
RU2098085C1 |
| MEDICINAL AGENT FOR ARRESTING SYNDROME OF SYSTEMIC INFLAMMATORY RESPONSE | 2004 |
|
RU2280455C2 |
| BIOLOGICALLY ACTIVE COMPOSITION WITH ADAPTOGENIC ACTION | 2015 |
|
RU2620562C2 |
| ANTIHYPOXANT AND METHOD FOR PREPARING IT | 2013 |
|
RU2506074C1 |
| PHARMACEUTICAL COMPOSITION AND METHOD OF PROPHYLAXIS, SUPPRESSION OR TREATMENT OF DISEASE ASSOCIATED WITH PRESENCE OF FREE RADICALS | 1993 |
|
RU2157213C2 |
| MEDICAL EMULSION OF PERFLUORORGANIC COMPOUNDS, METHOD OF PREPARATION AND METHOD OF APPLICATION | 2006 |
|
RU2393849C2 |
| METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES SUFFERING CARDIOVASCULAR RISK FACTORS AT AGE OF 45-60 YEARS OLD | 2013 |
|
RU2527357C1 |
| COMPOSITIONS COMPRISING SELENIUM AND USE OF SAME FOR THE TREATMENT AND PREVENTION OF DISEASE OR CONDITIONS ASSOCIATED WITH MITOCHONDRIAL DYSFUNCTION | 2014 |
|
RU2663127C2 |
| COMPOSITIONS AND METHODS FOR IMPROVING OR MAINTAINING MUSCLE PERFORMANCE | 2011 |
|
RU2606763C2 |
